BREAKING: House Passes One‑Month Hemp Ban Delay, Setting Up Clash Over Industry’s Future

The U.S. House of Representatives on Tuesday approved the Senate version of a continuing resolution to fund the government, adopting a one‑month delay of the federal hemp products ban that was set to take effect on November 12. The delay moves the implementation date to December 11 and gives lawmakers additional time to negotiate a regulatory framework for intoxicating hemp products. Synthetic cannabinoids not naturally produced by the cannabis plant will still be prohibited beginning November 12.

Jim Higdon, co‑founder of Cornbread Hemp, said the extension clarifies the path forward for hemp operators.

“This hemp extension ends the debate over whether low-dose hemp products should be regulated or subject to re-criminalization,” Higdon wrote in an emailed statement. “The work now is to write the regulations for full-spectrum CBD, topical and pet products, and low-dose THC beverages sold to American consumers in interstate commerce. We look forward to working with stakeholders towards that outcome between now and Dec. 11, to the benefit of farmers and consumers nationwide.”

The vote caps weeks of uncertainty for hemp operators, cannabis businesses, and lawmakers who have been divided over whether the federal government should ban intoxicating hemp products or regulate them under a new national system.

Hemp Industry Position: Regulate, Don’t Ban

Jonathan Miller, general counsel for the U.S. Hemp Roundtable, said in an interview with IgniteIt that he expected the House to approve the delay of the ban on hemp products with more than 0.4 milligrams of THC or other intoxicating cannabinoids until December. He added that “we are cautiously optimistic that we’ll be able to come up with a plan to regulate, not ban hemp by the December deadline.”

Miller said the Hemp Roundtable supports several pending bills to regulate hemp products, including a proposal from Rep. Andy Barr and Rep. Angie Craig, a separate measure from Sen. Ron Wyden, Rep. Morgan Griffith, and Rep. Marc Veasey, and an upcoming bill from Sen. Pete Ricketts and Sen. Amy Klobuchar. He said the group is hopeful that lawmakers will reach a bipartisan agreement on a regulatory framework.

He rejected the cannabis industry’s framing that the definitional change closes a loophole.

“It’s inaccurate. There’s no loophole to close,” Miller said. “There was a strong desire to have full-spectrum CBD products on the marketplace, and those would be banned if the language goes into effect.”

Miller said the Roundtable supports regulations that prevent youth access, eliminate copycat products, restrict imports from China, prohibit synthetic cannabinoids, and allow states to set their own limits. He added that the group sees political challenges around inhalable products but no ideological opposition.

Operators Warn of Economic Damage

Higdon of Cornbread Hemp, said the delay gives the industry a narrow window to establish a workable regulatory structure before the new definition takes effect in December. He added that the 0.4 milligram limit would cause widespread harm if Congress does not adopt a regulatory alternative.

“It’ll be devastating,” he said. “Farms will be lost over it. Businesses will go out of business. Jobs will be lost. It’ll be a setback to descheduling efforts because the pathway to interstate commerce that we have now will be destroyed.”

He said a workable regulatory framework would focus on non‑inhalable products with clear potency caps and age-gating to ensure they can only be purchased by adults.

“Five milligrams of total THC per serving seems to be where that’s headed,” he said, noting that supplements, beverages, topicals, and pet products could fit within that structure.

Higdon also warned of consequences for farmers.

“Farmers have financed those investments with loans from the bank, and the collateral for those loans is the farm,” he said. “We’re talking about generational wealth being wiped out because families lost farms for investing in hemp.”

Cannabis Industry Position: Keep the Loophole Closed

The U.S. Cannabis Roundtable supports the redefinition of hemp and says intoxicating hemp products should meet the same testing, packaging, potency, and access standards that apply in regulated cannabis markets.

“We have been very firm on a position that we support closing the intoxicating hemp loophole,” David Mangone, USCR’s senior vice president of government relations and policy, told IgniteIt in a recent interview. “If you are going to sell a product that has similar constructs and intoxicating effects as THC that’s available in the dispensary, it should be subject to the same regulations and guardrails that our membership adheres to as part of state regulatory systems.”

Mangone added that the products at issue share the same basic characteristics, even if they’re marketed under different labels.

“You’re looking at products from really the same underlying class that are being regulated tremendously differently,” he said.

Mangone said closing the loophole would bring more consumers into regulated systems, especially in states without legal cannabis markets. He cited polling showing that half of consumers currently buying intoxicating hemp products would obtain a medical card and transition to regulated cannabis if the definitional change takes effect.

White House Shift: Preserve Access to Full‑Spectrum CBD

President Trump signed the legislation that includes the intoxicating hemp products ban. Since then, the White House has changed course.

In an April 23 social media post, Trump wrote that he was “calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress’s intent to restrict the sale of products that pose Health risks.”

In June, the Office of Management and Budget reported that the Trump administration “welcomes the opportunity to work with the Congress to, at a minimum, update the statutory definition of final hemp-derived cannabinoid products to allow Americans to benefit from access to appropriate full-spectrum CBD products,” the agency wrote, “while preserving the Congress’s intent to restrict the sale of products that pose serious health risks.”

Congress Splits Into Two Factions

Congress has divided into two clear blocs in the debate over intoxicating hemp products.

Lawmakers Seeking Regulation Instead of a Ban

Several bipartisan bills would replace the ban with a regulatory framework.

Rep. Andy Barr of Kentucky and Rep. Angie Craig of Minnesota introduced the Lawful Hemp Protection Act. Barr said the bill is designed to support farmers and create national consistency.

“Kentucky farmers helped build America’s hemp industry and they deserve certainty,” Barr said in a statement about the legislation. “Kentucky has demonstrated that hemp can be successfully regulated while supporting farmers and protecting consumers. This legislation builds on that success by creating a national framework that rewards responsible producers, eliminates bad actors, and ensures consumers have confidence in the products they purchase.”

Another proposal, the Beverage Regulatory Parity Act, was introduced by Rep. Beth Van Duyne of Texas and Rep. Greg Landsman of Ohio. Landsman said the bill would protect businesses that have operated safely under existing rules.

“There are people all over Southwest Ohio who have invested significantly in these products, and they’ve done so safely,” Landsman said. “Now the federal government is telling them they can’t sell these products anymore. Our bill is bipartisan and very straightforward. It will keep people safe and let these folks stay in business.”

Other bills mentioned by Higdon include proposals from Sen. Ron Wyden, Rep. Morgan Griffith and Rep. Marc Veasey, and an upcoming bill from Sen. Pete Ricketts and Sen. Amy Klobuchar.

Lawmakers and State Officials Seeking to Keep the Ban in Place

Efforts to keep the ban on schedule centered on an amendment from Sen. Ted Budd to the Senate’s continuing resolution. Budd’s amendment would have removed the delay and preserved the original November 12 implementation date.

“The intoxicating hemp industry wants to make a cheap dollar,” Budd said, according to a report from Marijuana Moment. “I am appalled at the well‑oiled, slick lobbying machine, which is very well connected in this town, by the way, that has chosen to wage this surreptitious war against our efforts to protect American children.”

In addition to congressional supporters, a coalition of 35 state attorneys general sent a letter to congressional leaders on August 4, urging them to keep the ban in place.

“If the loophole is reopened or the new definition is weakened or repealed, States will face renewed litigation, inconsistent enforcement, regulatory uncertainty, increased youth access to intoxicating products, and disruption of lawful businesses that have already adjusted their operations to comply with the new federal framework,” the letter reads. “Equally as concerning, change at this stage would allow the return of unregulated intoxicating cannabis products that Congress appropriately chose to address.”

What Happens Next

With the House and Senate both approving the one‑month delay, the ban is now scheduled to take effect on December 11. Lawmakers will use the additional time to negotiate whether intoxicating hemp products should be prohibited outright or regulated under a new federal framework.

As Congress returns in September, both factions are preparing for another round of debate over the future of intoxicating hemp products.